Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (71%) |
| §112 only | 1 (14%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, REI TSANG | 1 | 80.0% | -34.5% |
| CHANG, KYUNG SOOK | 1 | 60.3% | +41.2% |
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
| MARCSISIN, ELLEN JEAN | 1 | 32.8% | +48.6% |
| WU, JULIE ZHEN QIN | 1 | 61.8% | +52.2% |
| MCKILLOP, JOHN CHARLES | 1 | 53.5% | +42.4% |
| TRAN, CHRISTINA L | 1 | 46.8% | +51.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | SHIAO, REI TSANG | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17284919 | The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy | TRAN, CHRISTINA L | 37d overdue |
| 18014947 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Peptide Epitopes | WANG, RUIXUE | 19d overdue |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | MARCSISIN, ELLEN JEAN | 8d overdue |
| 18276540 | Pectin Compositions and Methods of Use | CHANG, KYUNG SOOK | 3d overdue |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | WU, JULIE ZHEN QIN | 22d |
| 17291922 | An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescence | MCKILLOP, JOHN CHARLES | 28d |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| 1691 | 1 |
| 1613 | 1 |
| 1672 | 1 |
| 1677 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | SHIAO, REI TSANG | 1691 | §103 | Final Rejection | 70d | Pending | Aug 21, 2023 |
| 18276540 | Pectin Compositions and Methods of Use | CHANG, KYUNG SOOK | 1613 | §103 | Non-Final OA | 3d overdue | Pending | Aug 09, 2023 |
| 18014947 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Peptide Epitopes | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 19d overdue | Pending | Jan 06, 2023 |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | MARCSISIN, ELLEN JEAN | 1677 | Other | Non-Final OA | 8d overdue | Pending | Dec 21, 2022 |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | WU, JULIE ZHEN QIN | 1644 | §103 | Non-Final OA | 22d | Pending | Mar 18, 2022 |
| 17291922 | An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescence | MCKILLOP, JOHN CHARLES | 1637 | §103 | Non-Final OA | 28d | Pending | May 06, 2021 |
| 17284919 | The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy | TRAN, CHRISTINA L | 1637 | §112 | Final Rejection | 37d overdue | Pending | Apr 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial